By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sorrento Therapeutics, Inc. 



San Diego  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Sorrento Therapeutics, Inc. To Present At Two Healthcare Conferences 9/5/2014 12:17:20 PM
Sorrento Therapeutics, Inc. Awarded National Institutes of Health (NIH) Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 8/26/2014 9:25:40 AM
Sorrento Therapeutics, Inc. Appoints Douglas Ebersole To Its Board Of Directors 8/11/2014 8:16:55 AM
Sorrento Therapeutics, Inc. The Unexpected Death Of Its Chief Business Officer 8/1/2014 7:08:51 AM
Sorrento Therapeutics, Inc. Awarded Grant From The National Institutes of Health (NIH) For The Development Of A Small Molecule Myc Inhibitor 7/21/2014 1:05:19 PM
Sorrento Therapeutics, Inc. Awarded Grant From The National Institutes Of Health For The Development Of A Small Molecule Myc Inhibitor 7/21/2014 12:52:49 PM
Sorrento Therapeutics, Inc. Awarded Up To $2.6 Million From The National Institutes of Health (NIH) For The Development Of New Anti-Bacterial Bispecific Antibodies And Antibody Formulated Drug Conjugates 7/1/2014 11:13:06 AM
Morphotek Inc. And Sorrento Therapeutics, Inc. Sign An Exclusive Research And Option Agreement To Generate And Develop Morphotek Antibody Drug Conjugates 6/25/2014 7:04:46 AM
Sorrento Therapeutics, Inc. Announces Confidential Submission Of Draft Registration Statement For Initial Public Offering (IPO) Of Its Wholly-Owned Subsidiary Ark Animal Health With The SEC 6/23/2014 7:39:56 AM
Sorrento Therapeutics, Inc. To Present At Biotechnology Industry Organization (BIO) Business Forum 6/23/2014 6:24:46 AM
1234567
//-->